{"id": "1374377033468239875", "creation": 1616511994.0, "user_id": "952742605917274112", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "RT @globaltimesnews: CanSino's #COVID19 nasal-spray #vaccine gets approval Monday to start clinical trials, drawing same virus species and technology of the company\u2019s recombinant COVID-19 vaccine, which is already in use, but with better efficacy. https://t.co/e5td5IW4ZX", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}